Results 231 to 240 of about 117,022 (301)

Efficacy and safety of brodalumab in palmoplantar pustulosis: A 68‐week randomized Phase 3 trial

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 5, Page 887-899, May 2026.
This open‐label study is a continuation of the 16‐week double‐blind, Phase 3 trial assessing the efficacy and safety of brodalumab 210 mg subcutaneously, till a 68‐week extension period. Continued improvement was seen in the PPPASI 50/75/90 responses, PPPSI scores, PGA 0/1 responses and DLQI. Abstract Background The efficacy and safety of brodalumab in
Masamoto Murakami   +6 more
wiley   +1 more source

The Prevalence Rates of Acute Rheumatic Fever in Africa: A Systematic Review and Meta-Analysis. [PDF]

open access: yesSage Open Pediatr
Chinawa JM   +4 more
europepmc   +1 more source

Clinical Patterns of Osteoarticular, Bone Marrow and Urogenital Paracoccidioidomycosis

open access: yesMycoses, Volume 69, Issue 5, May 2026.
ABSTRACT Background Paracoccidioidomycosis (PCM) is an endemic systemic mycosis in Latin America, classically characterized by pulmonary, mucosal and lymphatic involvement. Extrapulmonary manifestations affecting uncommon organs remain poorly characterized and may contribute to diagnostic delay and adverse outcomes. Methods We conducted a retrospective
Wdson Luis Lima Kruschewsky   +7 more
wiley   +1 more source

The Service Economy [PDF]

open access: yes
Victor R. Fuchs
core  

Home - About - Disclaimer - Privacy